| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,515 | 7,315 | 6,896 | 14,038 | | Cost of Revenue | 3,643 | 4,706 | 6,264 | 16,251 | | | Gross Profit | 1,873 | 2,609 | 633 | (2,212) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (6,994) | 1,597 | 1,078 | 5,452 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 741 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 229 | 1,012 | (445) | (8,406) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 209 | 18 | 20 | 1,262 | | Earnings Before Interest And Taxes | (2,016) | 1,030 | (426) | (7,144) | | Interest Expense | (2,004) | 394 | 383 | 620 | | Income Before Tax | (12) | 636 | (809) | (7,763) | | Income Tax Expense |
-
| (472) | 476 | (371) | | Minority Interest | 64 | 31 |
-
| 12 | | | | Net Income From Continuing Ops | 53 | 1,139 | (1,285) | (7,380) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53 | 1,139 | (1,285) | (7,380) | | Preferred Stock And Other Adjustments |
-
| (28) | 28 | 0 | | | Net Income Applicable To Common Shares | $53 | $1,110 | ($1,257) | ($7,380) |
|
0.11% Nasdaq 
Income Statement
